KOD Latest Press Releases

-- October 7, 2026 --

Kodiak Sciences to Present Clinical Data Across All Three Late-Stage Programs at AAO 2026 PRNewswire 7:00 AM

-- September 28, 2026 --

4 Explosive Stories Enter the Investor Spotlight Globe Newswire 11:51 AM

-- September 25, 2026 --

Kodiak Sciences to Present Topline Results on September 28, 2026 from DAYBREAK Pivotal Phase 3 Study of Zenkuda and KSI-501 in Patients with Wet Age-Related Macular Degeneration PRNewswire 6:02 PM

-- August 13, 2026 --

Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2026 Financial Results PRNewswire 4:00 PM

-- August 10, 2026 --

Kodiak Sciences Announces First Patients Enrolled in Global Phase 3 ALTO trial of KSI-501 in Patients with Diabetic Macular Edema PRNewswire 4:44 PM

-- August 6, 2026 --

Kodiak Sciences Completes Enrollment in First Pivotal Cohort in the Phase 3 PEAK Trial of KSI-101 for Macular Edema Secondary to Inflammation and Reaffirms Topline Clinical Data Release Remains on Track for December 2026 PRNewswire 7:00 AM

Market Data Delayed 15 Minutes